en · de · es · fr · pt
dihexa-notes.peptides6088.com › Faq › Overview And Research Status — Beginner to Advanced

Overview And Research Status — Beginner to Advanced

By Editorial Desk · published 2026-02-16 · last reviewed 2026-03-10 · Faq

The short version of Angiotensin IV analog fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-03-10. Anything still debated is marked as such rather than presented as settled.

Overview and Research Status

Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.

Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.

Research Evidence and Regulation

Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.

Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.

Dihexa at a glance

PropertyValueNotes
CAS Registry Number1401708-83-5Identifier used in chemical databases.
Common synonymsP21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide)Names vary by supplier and publication.
Physical formWhite to off-white powderLyophilized solid typical of peptides.
SolubilitySoluble in DMSO; limited in waterAqueous preparation may need a co-solvent.
Storage-20 °C, desiccated, protected from lightReduce freeze-thaw cycles to maintain stability.

Mechanism And Laboratory Characterization

Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.

Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.

Related pages on this site

Identity And Regulatory Status

Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.

Chemically, dihexa is a short peptide-like molecule with nonstandard components. Its structure includes tyrosine and isoleucine residues linked to a hexanoic acid group and an aminohexanoic amide segment. This design distinguishes it from endogenous angiotensin IV, though the two are discussed together because of shared origins. Published summaries classify it as a small synthetic peptide with lipophilic features that may influence how it crosses biological barriers in experimental systems. Exact conformational details depend on the specific salt or free base form.

Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.

Notes from published material

==== Other drugs ==== Acamprosate (Alcomed; Aotal; calcium acetylhomotaurinate; Campral; Campral EC; NS-11; Regtect; Sobriol; Zulex) – various actions – alcoholism Baclofen (Baclocur) – GABAB receptor agonist – alcoholism Calcium carbimide (Temposil) – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism Cyanamide – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism Disulfiram (Antabuse, Antabus) – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism Flumazenil (flumazepil; Anexate) – GABAA receptor negative allosteric modulator/benzodiazepine antidote – benzodiazepine overdose Lofexidine (BA-168; BritLofex; Lucemyra; MDL-14042; MDL-14042A; RMI-14042A) – α2-adrenergic receptor agonist – opioid-related disorders Sodium oxybate (Alcover; SMO immediate release formulation) – GABAB and GHB receptor agonist – alcoholism

Originally, René Just Haüy considered that each chemical compound had a characteristic crystalline form. However, based on his 1808 work with aragonite and his earlier studies of calcite, which are two different forms of calcium carbonate (CaCO3), Haüy had to concede that substances with the same chemical composition but different molecular arrangements could have different crystalline forms. In 1819 Eilhard Mitscherlich discovered the law of isomorphism which states that compounds which contain the same number of atoms, and have similar structures, tend to exhibit similar crystal forms. Mitscherlich carried out the first systematic research on the dependence of crystal forms on their chemical nature. The discovery of isomorphism was the first major step in chemical crystallography and Emil Wohlwill regarded Mitscherlich's work on isomorphism as a milestone in the history of the atomic-molecular theory. The discovery of the phenomena of isomorphism and polymorphism dealt a clear blow to Haüy's crystal structure theory. Mitscherlich's findings were a central consideration of the atomic weight determinations in 1819 by Jöns Jacob Berzelius, a leading proponent of Dalton's atomic theory. Berzelius classified minerals by their chemical composition rather than by their crystal morphology, as was the established practice. Mitscherlich's research, together with the work of Alexis Thérèse Petit and Pierre-Louis Dulong that heat capacities of solids vary with temperature and inversely with atomic weight, led Berzelius to declare them as a positive confirmation of the atomic theory.

=== Production, anaerobic conditions === Fermentation is the metabolism of organic compounds in the absence of air. It involves substrate-level phosphorylation in the absence of a respiratory electron transport chain. The equation for the reaction of glucose to form lactic acid is:

Sources: en.wikipedia.org

Background from the literature

Broad range of healing philosophies, approaches, and therapies that Western (conventional) medicine does not commonly use to promote well-being or treat health conditions. Examples include acupuncture, herbs, etc. Internet Address: http://www.nccih.nih.gov. (NLM) Compliance

The soybean, soy bean, or soya bean (Glycine max) is a species of legume native to East Asia, widely grown for its edible bean. Soy is a staple crop, the world's most grown legume, and an important animal feed. Soy is a key food source, owing to its high protein and oil content. Soybean oil is widely used in cooking, as well as in industry. Traditional unfermented food uses of soybeans include edamame, as well as soy milk, from which tofu and tofu skin are made. Fermented soy foods include soy sauce, fermented bean paste, nattō, and tempeh. Fat-free (defatted) soybean meal is a significant and cheap source of protein for animal feeds and many packaged meals. For example, soybean products, such as textured vegetable protein (TVP), are ingredients in many meat and dairy substitutes. Soy-based foods are traditionally associated with East Asian cuisines, and still constitute a major part of East Asian diets, but processed soy products are increasingly used in Western cuisines. Soy was domesticated from the wild soybean (Glycine soja) in north-central China between 6,000 and 9,000 years ago. Brazil and the United States lead the world in modern soy production. The majority of soybeans are genetically modified, usually for either insect, herbicide, or drought resistance. Three-quarters of soy is used to feed livestock, which in turn go to feed humans. Increasing demand for meat has substantially increased soy production since the 1980s, and contributed to deforestation in the Amazon. Soybeans contain significant amounts of phytic acid, dietary minerals, and B vitamins.

=== Current === Alex Lifeson – electric and acoustic guitars, backing vocals, synthesizers, keyboards (1968–2015, 2025–present) Geddy Lee – lead and backing vocals, bass, keyboards, synthesizers, guitar (1968–1969, 1969–2015, 2025–present), lyrics (1973–1974)

=== Genetic predisposition === The genetic locus most significantly associated with Sjögren’s is the major histocompatibility complex/human leukocyte antigen (MHC/HLA) region, as demonstrated by the preliminary results of the first genome-wide association study. This study included data from a discovery cohort of 395 patients of European ancestry with primary Sjögren's disease, and 1,975 healthy control individuals, and from a replication study that comprised 1,234 cases and 4,779 healthy controls. Associations with polymorphisms located at six independent loci were also detected; IRF5, STAT4, BLK, IL12A, TNIP1, and CXCR5. This also suggested the activation of the innate immune system, notably through the IFN system, B-cell activation through CXCR5-directed recruitment to lymphoid follicles and B-cell receptor (BCR) activation involving BLK, and T-cell activation owing to HLA susceptibility and the IL-12-IFN-γ-axis. Patients of different ethnic origins carry different HLA-susceptibility alleles, of which HLA-DR and HLA-DQ are involved in the pathogenesis of Sjögren's disease. For example, patients from Northern and Western Europe and North America show a high prevalence of B8, DRw52, and DR3 genes. HLA class II alleles are associated with the presence of specific subsets of autoantibodies, rather than with the disease itself. Autoantibodies refer to the loss of B-cell tolerance leading to the production of antibodies directed against diverse organ-specific and organ-nonspecific antigens.

Sources: en.wikipedia.org

Further detail

The epic Mahabharata details the use of multi-tiered military formation that resembles a blooming lotus called Padmavyuha and its disc-shaped variant Chakravyuha in the 18-day long Kurukshethra war.Padmasana, or the lotus pose, in yoga and Sahasrara, the thousand petalled lotus chakra, in tantra are some examples of the use of lotus imagery. Lotus motifs are found in Indian architecture, for example: domes resembling lotus buds, pillars resembling lotus stalk, arches resembling inverted lotus, and other lotus engravings in Hindu and Buddhist temples.In Asian art, a lotus throne is a stylized lotus flower used as the seat or base for a figure in Buddhist art and Hindu art and is often seen in Jain art. Originating in Indian art, it followed Indian religions to East Asia in particular. Lotus flowers are also often held by figures.The Nelumbo nucifera, which is also called Nilufar Abi in Persian, can be seen in many reliefs of the Achaemenid period (552 BC) such as the statue of Anahita in the Persepolis. The lotus flower was included in Kaveh the blacksmith's Derafsh and later as the flag of the Sasanian Empire Derafsh Kaviani. Today, it is the symbol of the Iranian Solar Hijri calendar. The lotus flower is also mentioned in the Bible. The lotus flower also holds cultural and religious significance in Ismaili Muslim and related South Asian traditions. For example, in South Asian Ismaili literature, the lotus is compared to the pure soul. A poem describes the lotus' beauty, describing how its delicate white petals remain pure and beautiful, despite its murky environment.

21 April In one of the first Fragging incidents of the war, a grenade was thrown into the office of K Company, 9th Marine Regiment, at Quảng Trị Combat Base, killing First Lieutenant Robert T. Rohweller. Private Reginald F. Smith pleaded guilty to the premeditated murder and was sentenced to 40 years' imprisonment; he died in custody on 25 June 1982.

== Technology == Dr. Werner Baumgartner was responsible for founding Psychemedics and spearheading its initial research. A nationally recognized expert on drug testing through hair samples, Dr. Baumgartner gained acclaim by procuring some strands of hair from the 19th-century poet John Keats. Despite the age of the hair, Baumgartner was able to detect that the poet, who died at the age of 26 from tuberculosis, had been taking an increasing amount of opium before his death, most likely used in painkillers. Dr. Baumgartner's find created a minor sensation, enough to warrant a mention in a 1985 Time magazine cover story about drugs in the workplace. After years of research proved that drugs deposited in the hair can be accurately measured, the company was formed in 1987 and pioneered the use of hair testing in commercial markets including banks, manufacturers, retailers, mining operations, hotels and casinos. The technology capitalizes on the way the body metabolizes ingested drugs as they flow through the blood stream and deposit in the cortex of the hair. Hair is stable and the deposits are permanently embedded in the hair, so hair acts like a tape recorder — “recording” drug deposits in proportion to use over time as drugs are deposited in proportion to use. Hair grows at approximately the rate of ½ an inch per month and takes about 5 days to grow out past the external layer of skin. Psychemedics’ standard test uses a 1 ½ inch sample of head hair, which provides an approximate 3 month history of drug use. Body hair can also be collected if head hair is not available.

Sources: en.wikipedia.org

Frequently asked questions

What is dihexa?

Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.

Is dihexa approved for human use?

No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.

What is dihexa studied for?

Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.

Has dihexa been tested in humans?

Published human trials are lacking. Most evidence comes from laboratory and animal studies. Therefore, human benefits and risks are not established.

Network